SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Fresenius Medical Care AG – ‘20-F’ for 12/31/23 – ‘EX-97’

On:  Tuesday, 2/20/24, at 10:02am ET   ·   For:  12/31/23   ·   Accession #:  1104659-24-25293   ·   File #:  1-32749

Previous ‘20-F’:  ‘20-F’ on 2/22/23 for 12/31/22   ·   Latest ‘20-F’:  This Filing   ·   17 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  Fresenius Medical Care AG         20-F       12/31/23  204:52M                                    Toppan Merrill/FA

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer   —   Form 20-F   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual or Annual-Transition Report by a Foreign     HTML  11.74M 
                Non-Canadian Issuer                                              
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    107K 
 3: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    122K 
                Liquidation or Succession                                        
 4: EX-2.2      Plan of Acquisition, Reorganization, Arrangement,   HTML    434K 
                Liquidation or Succession                                        
 6: EX-4.12     Instrument Defining the Rights of Security Holders  HTML    117K 
 7: EX-4.17     Instrument Defining the Rights of Security Holders  HTML    141K 
 8: EX-4.18     Instrument Defining the Rights of Security Holders  HTML    772K 
 9: EX-4.19     Instrument Defining the Rights of Security Holders  HTML   1.27M 
10: EX-4.20     Instrument Defining the Rights of Security Holders  HTML    167K 
 5: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     70K 
14: EX-13.1     Annual or Quarterly Report to Security Holders      HTML     58K 
15: EX-13.2     Annual or Quarterly Report to Security Holders      HTML     58K 
16: EX-97       Clawback Policy re: Recovery of Erroneously         HTML    151K 
                Awarded Compensation                                             
11: EX-11.3     Statement re: the Computation of Earnings Per       HTML    166K 
                Share                                                            
12: EX-12.1     Statement re: the Computation of Ratios             HTML     62K 
13: EX-12.2     Statement re: the Computation of Ratios             HTML     62K 
22: R1          Document and Entity Information                     HTML    138K 
23: R2          Consolidated statements of income                   HTML    120K 
24: R3          Consolidated statements of comprehensive income     HTML    107K 
25: R4          Consolidated balance sheets                         HTML    171K 
26: R5          Consolidated balance sheets (Parenthetical)         HTML     64K 
27: R6          Consolidated statements of cash flows               HTML    160K 
28: R7          Consolidated statements of shareholders' equity     HTML    124K 
29: R8          The Company, basis of presentation and significant  HTML    317K 
                accounting policies                                              
30: R9          Significant judgments and sources of estimation     HTML    211K 
                uncertainties                                                    
31: R10         Acquisitions, business combinations, investments    HTML     86K 
                (including debt securities), purchases of                        
                intangible assets, divestitures and sale of debt                 
                securities                                                       
32: R11         Disposal groups classified as held for sale         HTML     84K 
33: R12         Notes to the consolidated statements of income      HTML    441K 
34: R13         Related party transactions                          HTML    201K 
35: R14         Cash and cash equivalents                           HTML     66K 
36: R15         Trade accounts and other receivables from           HTML    198K 
                unrelated parties                                                
37: R16         Inventories                                         HTML     69K 
38: R17         Other current financial and non-financial assets    HTML     91K 
39: R18         Property, plant and equipment                       HTML    271K 
40: R19         Intangible assets and goodwill                      HTML    469K 
41: R20         Interests in associates                             HTML    130K 
42: R21         Other non-current financial assets                  HTML     71K 
43: R22         Current provisions and other current financial and  HTML    135K 
                non-financial liabilities                                        
44: R23         Short-term debt                                     HTML     72K 
45: R24         Long-term debt                                      HTML    153K 
46: R25         Non-current provisions and other non-current        HTML    135K 
                financial and non-financial liabilities                          
47: R26         Employee benefit plans                              HTML    299K 
48: R27         Shareholders' equity                                HTML     83K 
49: R28         Capital management                                  HTML     84K 
50: R29         Earnings per share                                  HTML     76K 
51: R30         Share-based plans                                   HTML    217K 
52: R31         Leases                                              HTML    252K 
53: R32         Commitments and contingencies                       HTML     91K 
54: R33         Financial instruments                               HTML    651K 
55: R34         Other comprehensive income (Loss)                   HTML    149K 
56: R35         Supplementary cash flow information                 HTML    203K 
57: R36         Segment and corporate information                   HTML    289K 
58: R37         Subsequent events                                   HTML     59K 
59: R38         Compensation of the Management Board and the        HTML     63K 
                Supervisory Board                                                
60: R39         Principal accountant fees and services              HTML     91K 
61: R40         The Company, basis of presentation and significant  HTML    327K 
                accounting policies (Policies)                                   
62: R41         The Company, basis of presentation and significant  HTML    228K 
                accounting policies (Tables)                                     
63: R42         Significant judgments and sources of estimation     HTML    173K 
                uncertainties (Tables)                                           
64: R43         Acquisitions, business combinations, investments    HTML     75K 
                (Including Debt Securities), Purchases of                        
                Intangible Assets, Divestitures and Sale of Debt                 
                Securities (Tables)                                              
65: R44         Disposal groups classified as held for sale         HTML     78K 
                (Tables)                                                         
66: R45         Notes to the consolidated statements of income      HTML    439K 
                (Tables)                                                         
67: R46         Related party transactions (Tables)                 HTML    189K 
68: R47         Cash and cash equivalents (Tables)                  HTML     66K 
69: R48         Trade accounts and other receivables from           HTML    199K 
                unrelated parties (Tables)                                       
70: R49         Inventories (Tables)                                HTML     67K 
71: R50         Other current financial and non-financial assets    HTML     90K 
                (Tables)                                                         
72: R51         Property, plant and equipment (Tables)              HTML    271K 
73: R52         Intangible assets and goodwill (Tables)             HTML    470K 
74: R53         Interests in associates (Tables)                    HTML    130K 
75: R54         Other non-current financial assets (Tables)         HTML     70K 
76: R55         Current provisions and other current financial and  HTML    133K 
                non-financial liabilities (Tables)                               
77: R56         Short-term debt (Tables)                            HTML     68K 
78: R57         Long-term debt (Tables)                             HTML    148K 
79: R58         Non-current provisions and other non-current        HTML    135K 
                financial and non-financial liabilities (Tables)                 
80: R59         Employee benefit plans (Tables)                     HTML    292K 
81: R60         Capital management (Tables)                         HTML     82K 
82: R61         Earnings per share (Tables)                         HTML     76K 
83: R62         Share-based plans (Tables)                          HTML    196K 
84: R63         Leases (Tables)                                     HTML    249K 
85: R64         Financial instruments (Tables)                      HTML    639K 
86: R65         Other comprehensive income (Loss) (Tables)          HTML    148K 
87: R66         Supplementary cash flow information (Tables)        HTML    203K 
88: R67         Segment and corporate information (Tables)          HTML    285K 
89: R68         Principal accountant fees and services (Tables)     HTML     87K 
90: R69         The Company, basis of presentation and significant  HTML    137K 
                accounting policies (Details)                                    
91: R70         The Company, basis of presentation and significant  HTML     90K 
                accounting policies - The Company's interest in                  
                subsidiaries (Details)                                           
92: R71         The Company, basis of presentation and significant  HTML     69K 
                accounting policies - Property, plant and                        
                equipment (Details)                                              
93: R72         The Company, basis of presentation and significant  HTML     75K 
                accounting policies - Intangible assets and                      
                goodwill (Details)                                               
94: R73         The Company, basis of presentation and significant  HTML     60K 
                accounting policies - Foreign currency translation               
                (Details)                                                        
95: R74         The Company, basis of presentation and significant  HTML     61K 
                accounting policies - Capitalized interest                       
                (Details)                                                        
96: R75         The Company, basis of presentation and significant  HTML     60K 
                accounting policies - Concentration of risk                      
                (Details)                                                        
97: R76         The Company, basis of presentation and significant  HTML     66K 
                accounting policies - Recent pronouncements                      
                (Details)                                                        
98: R77         Significant judgments and sources of estimation     HTML    154K 
                uncertainties - Recoverability of goodwill and                   
                intangible assets (Details)                                      
99: R78         Significant judgments and sources of estimation     HTML     73K 
                uncertainties - Trade accounts and other                         
                receivables from unrelated parties and expected                  
                credit losses (Details)                                          
100: R79         Significant judgments and sources of estimation     HTML     73K  
                uncertainties - Percentage of Accounts Receivable                
                (Details)                                                        
101: R80         Acquisitions, business combinations, investments    HTML     82K  
                (including debt securities), purchases of                        
                intangible assets, divestitures and sale of debt                 
                securities - Acquisitions (Details)                              
102: R81         Acquisitions, business combinations, investments    HTML     73K  
                (Including Debt Securities), Purchases of                        
                Intangible Assets, Divestitures and Sale of Debt                 
                Securities (Details)                                             
103: R82         Acquisitions, business combinations, investments    HTML     82K  
                (including debt securities) and purchases of                     
                intangible assets - Fair Values of Assets Acquired               
                and Liabilities Assumed (Details)                                
104: R83         Acquisitions, business combinations, investments    HTML     74K  
                (including debt securities), purchases of                        
                intangible assets, divestitures and sale of debt                 
                securities - Divestitures and sale of debt                       
                securities (Details)                                             
105: R84         Disposal groups classified as held for sale         HTML     72K  
                (Details)                                                        
106: R85         Disposal groups classified as held for sale -       HTML     94K  
                Assets and liabilities of disposal groups                        
                classified as held for sale (Details)                            
107: R86         Notes to the consolidated statements of income -    HTML     74K  
                Revenue (Details)                                                
108: R87         Notes to the consolidated statements of income -    HTML     76K  
                Disaggregation of revenue by categories (Details)                
109: R88         Notes to the consolidated statements of income -    HTML     66K  
                Trade accounts receivables and contract                          
                liabilities (Details)                                            
110: R89         Notes to the consolidated statements of income -    HTML     68K  
                Unsatisfied performance obligations (Details)                    
111: R90         Notes to the consolidated statements of income -    HTML     63K  
                Selling, general and administrative expense                      
                (Details)                                                        
112: R91         Notes to the consolidated statements of income -    HTML     58K  
                Research and development expenses (Details)                      
113: R92         Notes to the consolidated statements of income -    HTML     62K  
                Cost of materials (Details)                                      
114: R93         Notes to the consolidated statements of income -    HTML     80K  
                Personnel expenses (Details)                                     
115: R94         Notes to the consolidated statements of income -    HTML     95K  
                Other operating income and expense (Details)                     
116: R95         Notes to the consolidated statements of income -    HTML     83K  
                Expenses from strategic transactions and programs                
                (Details)                                                        
117: R96         Notes to the consolidated statements of income -    HTML     62K  
                Net interest (Details)                                           
118: R97         Notes to the consolidated statements of income -    HTML     80K  
                Income taxes geographical (Details)                              
119: R98         Notes to the consolidated statements of income -    HTML     88K  
                Income taxes reconciliation (Details)                            
120: R99         Notes to the consolidated statements of income -    HTML     95K  
                Deferred income tax assets and liabilities                       
                (Details)                                                        
121: R100        Notes to the consolidated statements of income -    HTML     63K  
                Net deferred income tax assets and liabilities                   
                (Details)                                                        
122: R101        Notes to the consolidated statements of income -    HTML     95K  
                Net operating loss carryforwards (Details)                       
123: R102        Notes to the consolidated statements of income -    HTML     68K  
                Impacts of COVID-19 (Details)                                    
124: R103        Related party transactions - Service agreements     HTML     83K  
                and products - General (Details)                                 
125: R104        Related party transactions - Service agreements     HTML     91K  
                and products with related parties (Details)                      
126: R105        Related party transactions - Lease Agreements -     HTML     87K  
                Summary (Details)                                                
127: R106        Related party transactions - Financing (Details)    HTML     88K  
128: R107        Related party transactions - Key management         HTML     89K  
                personnel (Details)                                              
129: R108        Cash and cash equivalents (Details)                 HTML     65K  
130: R109        Trade accounts and other receivables from           HTML     81K  
                unrelated parties (Details)                                      
131: R110        Trade accounts and other receivables from           HTML     73K  
                unrelated parties - Development of expected credit               
                losses (Details)                                                 
132: R111        Trade accounts and other receivables from           HTML     88K  
                unrelated parties - Ageing analysis of trade                     
                accounts and other receivables from unrelated                    
                parties and the allowance for doubtful accounts                  
                (Details)                                                        
133: R112        Trade accounts and other receivables from           HTML     93K  
                unrelated parties - Reconciliation of portfolios                 
                of insurance and reinsurance contracts (Details)                 
134: R113        Inventories (Details)                               HTML     80K  
135: R114        Other current financial and non-financial assets    HTML     89K  
                (Details)                                                        
136: R115        Property, plant and equipment (Details)             HTML    172K  
137: R116        Intangible assets and goodwill - Acquisition or     HTML    264K  
                manufacturing costs of intangible assets and                     
                goodwill (Details)                                               
138: R117        Intangible assets and goodwill - Goodwill and       HTML     99K  
                intangible assets with indefinite useful Life                    
                (Details)                                                        
139: R118        Interests in associates (Details)                   HTML     66K  
140: R119        Interests in associates - Summarized balance        HTML     74K  
                sheets (Details)                                                 
141: R120        Interests in associates - Reconciliation to         HTML     84K  
                carrying amounts (Net assets) (Details)                          
142: R121        Interests in associates - Summarized statement of   HTML     82K  
                comprehensive income (Details)                                   
143: R122        Other non-current financial assets (Details)        HTML     63K  
144: R123        Current provisions and other current financial and  HTML    126K  
                non-financial liabilities (Details)                              
145: R124        Short-term debt (Details)                           HTML     89K  
146: R125        Long-term debt (Details)                            HTML     70K  
147: R126        Long-term debt - Schuldschein loans (Details)       HTML     63K  
148: R127        Long-term debt - Bonds (Details)                    HTML    114K  
149: R128        Long-term debt - Accounts Receivable Facility       HTML     64K  
                (Details)                                                        
150: R129        Long-term debt - Syndicated Credit Facility and     HTML     65K  
                Others (Details)                                                 
151: R130        Non-current provisions and other non-current        HTML    124K  
                financial and non-financial liabilities (Details)                
152: R131        Employee benefit plans - Defined benefit pension    HTML     99K  
                plans (Details)                                                  
153: R132        Employee benefit plans - Net pension liability      HTML    102K  
                (Details)                                                        
154: R133        Employee benefit plans - Pension plan assets and    HTML     81K  
                liabilities (Details)                                            
155: R134        Employee benefit plans - Weighted average           HTML     63K  
                assumptions for benefit obligations (Details)                    
156: R135        Employee benefit plans - Sensitivity analysis       HTML     76K  
                (Details)                                                        
157: R136        Employee benefit plans - Components of net          HTML     69K  
                periodic benefit cost (Details)                                  
158: R137        Employee benefit plans - Weighted average           HTML     62K  
                assumptions for periodic benefit cost (Details)                  
159: R138        Employee benefit plans - Defined benefit pension    HTML     67K  
                plans - cash outflows (Details)                                  
160: R139        Employee benefit plans - Plan Assets (Details)      HTML     91K  
161: R140        Employee benefit plans - Plan investment policy     HTML     65K  
                (Details)                                                        
162: R141        Employee benefit plans - Defined contribution       HTML     75K  
                plans (Details)                                                  
163: R142        Shareholders' equity - Capital stock (Details)      HTML    106K  
164: R143        Shareholders' equity - Authorized capital           HTML     69K  
                (Details)                                                        
165: R144        Shareholders' equity - Conditional capital          HTML     79K  
                (Details)                                                        
166: R145        Shareholders' equity - Treasury stock (Details)     HTML     59K  
167: R146        Shareholders' equity - Dividends (Details)          HTML     66K  
168: R147        Capital management (Details)                        HTML     70K  
169: R148        Earnings per share (Details)                        HTML     69K  
170: R149        Share-based plans (Details)                         HTML    159K  
171: R150        Share-based plans - Long-term incentive program     HTML     75K  
                2011 (Details)                                                   
172: R151        Share-based plans - Information on Holdings under   HTML     84K  
                Share-based Plans (Details)                                      
173: R152        Share-based plans - Stock options activity          HTML     75K  
                (Details)                                                        
174: R153        Share-based plans - Stock Options Exercise Price    HTML     79K  
                Range (Details)                                                  
175: R154        Share-based Plans - Stock Options Other Disclosure  HTML     63K  
                (Details)                                                        
176: R155        Share-based plans - Compensation Expense Related    HTML     73K  
                to Cash-Settled Plans (Details)                                  
177: R156        Leases - Leasing in the consolidated statements of  HTML     72K  
                income (Details)                                                 
178: R157        Leases - Leases in the consolidated balance sheets  HTML    111K  
                (Details)                                                        
179: R158        Leases - Leasing in the consolidated statements of  HTML     67K  
                cash flows (Details)                                             
180: R159        Commitments and contingencies (Details)             HTML    122K  
181: R160        Financial instruments - Carrying amount and fair    HTML    177K  
                value (Details)                                                  
182: R161        Financial instruments - Fair values of listed and   HTML     76K  
                non-listed equity investments (Details)                          
183: R162        Financial instruments - Derivative and              HTML    117K  
                non-derivative financial instruments (Details)                   
184: R163        Financial Instruments - Derivatives financial       HTML     67K  
                risks (Details)                                                  
185: R164        Financial Instruments - Foreign exchange risk       HTML     65K  
                management (Details)                                             
186: R165        Financial instruments - Foreign exchange risk       HTML     79K  
                (Details)                                                        
187: R166        Financial instruments - Interest rate risk          HTML     71K  
                (Details)                                                        
188: R167        Financial instruments - Derivative financial        HTML     77K  
                instruments valuation (Details)                                  
189: R168        Financial instruments - Effect of derivatives on    HTML    107K  
                consolidated financial statements (Details)                      
190: R169        Financial instruments - Derivatives, cash flow and  HTML     60K  
                credit risk (Details)                                            
191: R170        Financial instruments - Payments agreed by          HTML    131K  
                contracts (Details)                                              
192: R171        Other comprehensive income (Loss) (Details)         HTML    128K  
193: R172        Supplementary cash flow information (Details)       HTML     84K  
194: R173        Supplementary cash flow information -               HTML    105K  
                Reconciliation of debt to net cash provided by                   
                (Used In) Financing Activities (Details)                         
195: R174        Segment and corporate information (Details)         HTML    144K  
196: R175        Segment and corporate information - Geographic      HTML     72K  
                Information (Details)                                            
197: R176        Compensation of the Management Board and the        HTML     94K  
                Supervisory Board - Compensation of the Management               
                Board (Details)                                                  
198: R177        Compensation of the Management Board and the        HTML     62K  
                Supervisory Board - Compensation of the                          
                Supervisory Board (Details)                                      
199: R178        Principal accountant fees and services (Details)    HTML     67K  
201: XML         IDEA XML File -- Filing Summary                      XML    401K  
204: XML         XBRL Instance -- fms-20231231x20f_htm                XML  14.18M  
200: EXCEL       IDEA Workbook of Financial Report Info              XLSX    518K  
18: EX-101.CAL  XBRL Calculations -- fms-20231231_cal                XML    476K 
19: EX-101.DEF  XBRL Definitions -- fms-20231231_def                 XML   2.14M 
20: EX-101.LAB  XBRL Labels -- fms-20231231_lab                      XML   3.58M 
21: EX-101.PRE  XBRL Presentations -- fms-20231231_pre               XML   3.05M 
17: EX-101.SCH  XBRL Schema -- fms-20231231                          XSD    733K 
202: JSON        XBRL Instance as JSON Data -- MetaLinks              909±  1.55M  
203: ZIP         XBRL Zipped Folder -- 0001104659-24-025293-xbrl      Zip   3.28M  


‘EX-97’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <!  <> 

Exhibit 97

Graphic

Global Incentive-Based Compensation Recovery Policy

Type:

2 Policy

Version No.:

1

Reference No.:

13929

Scope:

Executives of the FME Group
(Current and former members of the Supervisory Board, the KGaA Supervisory Board, and the Management Board, and to the Company's other current and former Executive Officers)

Out of Scope:

n/a

Target Group:

n/a

Publication Date:

22/November/2023

Effective Date:

See below

Status:

Published

Owner’s Department:

Global Legal

Approver’s Position:

FME Management Board

Approver’s Position:

FME Supervisory Board

This document is internal and is the sole property of Fresenius Medical Care. It is issued by the Document Owner and is electronically published in the Policy Management database. Printouts of this document are for reference only. The user is always responsible for referring to the Policy Management database for the latest and valid version.

FOR INTERNAL USE ONLY

Page : 1 of 8


Graphic

Global Incentive-Based Compensation Recovery Policy

CONTENT

1

PURPOSE

3

2

DEFINITIONS

3

3

REQUIREMENTS / PROCESS

5

3.1

Executives Covered by this Policy

5

3.2

Amount of Excess Incentive-Based Compensation Subject to Recovery

5

3.3

Administration

6

3.4

Method of Recovery

6

3.5

Impracticability

7

3.6

Indemnification; Insurance

7

3.7

Effective Date

7

3.8

Amendment; Termination

7

3.9

Other Recovery Rights

7

3.10

Successors

8

3.11

Effect of Conversion of Legal Form

8

4

RELATED INTERNAL CONTROLS

8

5

RELATED DOCUMENTS

8

6

ANNEXES

8

FOR INTERNAL USE ONLY

Page : 2 of 8


Graphic

Global Incentive-Based Compensation Recovery Policy

1

PURPOSE

The Supervisory Board (the “Supervisory Board”) of Fresenius Medical Care Management AG, the General Partner of the Company (the “General Partner”), and the Management Board of the General Partner (the “Management Board”), as the respective competent bodies to determine and award the compensation of the members of the Management Board and of persons employed by the Company, including the Company’s “Executive Officers” (as defined herein), hereby adopt the policy set forth herein (the “Policy”) to provide for the recovery of certain executive compensation in the event of an “Accounting Restatement” (as defined in this Policy) resulting from material noncompliance with financial reporting requirements under the U.S. federal securities laws. This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934 (the “Exchange Act”), Rule 10D-1 adopted by the Securities and Exchange Commission (the “Commission”) thereunder, and Rule 303A.14 of the New York Stock Exchange (“NYSE”) Listed Company Rules.

2

DEFINITIONS

The terms used throughout this document are defined as per the Common Definition Framework. The following definitions are specific to this document:

Term

Definition

Accounting Restatement

Accounting Restatement” means a revision of financial statements previously issued by the Company constituting a restatement of such financial statements within the meaning of International Financial Reporting Standards (“IFRS”) as developed and maintained by the International Accounting Standards Board (“ IASB”) and the applicable guidance issued by the IASB with respect to IFRS, or such other internationally recognized set of accounting standards then being applied by the Company in the preparation of its financial statements filed with the Commission. Without limiting the generality of the foregoing, “Accounting Restatement” shall include (1) any required restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or (2) a required restatement to correct an error in previously issued financial statements that is not material to previously issued financial statements but would result in a material misstatement if (a) the error were left uncorrected in the current report or (b) were recognized in the current period.

Notwithstanding the foregoing, and for avoidance of doubt, none of the following shall constitute an Accounting Restatement:

a.Retrospective application of a change in accounting principle;

b.

Retrospective revision to reportable segment information due to a change in the structure of the Company’s internal organization;

c.

Retrospective reclassification due to a discontinued operation;

d.

Retrospective application of a change in reporting entity, such as from a reorganization of entities under common control;

e.

Retrospective adjustment to provisional amounts in connection with a prior business combination; or

f.

Retrospective revision for stock splits, reverse stock splits, stock dividends or other changes in capital structure.

Board(s)

Board” and “Boards” shall mean any or all of the Supervisory Board, the KGaA Supervisory Board (as defined below), and the Management Board, the context shall require.

Executive Officer

Executive Officer” means any member of the Supervisory Board, any member of the Management Board (including, for the avoidance of doubt, the Company’s Chief Executive Officer and Chief Financial Officer), any member of the Supervisory Board of the Company (the “KGaA Supervisory Board,the Company’s Chief Accounting Officer, and any officer or other person in charge of a principal business unit, division or function (such as sales, administration or finance) for the Company, any officer or other person who performs a policy-making function for the Company, and any person of a subsidiary of the Company who performs such a policy -making function for the Company. The determination of (i) the persons (other than Board members) in charge of a principal business unit, division or function for the Company, and (ii) the persons

FOR INTERNAL USE ONLY

Page : 3 of 8


Graphic

Global Incentive-Based Compensation Recovery Policy

(including persons of a subsidiary of the Company) who perform a policy -making function for the Company and are thus Executive Officers for purposes of this Policy, shall be made by the Management Board.

Financial Reporting Measures

Financial Reporting Measures ” means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures. A financial reporting measure used to determine the grant, earning or vesting of Incentive-Based Compensation need not be presented within the Company’s financial statements or included in a filing by the Company with the Commission. Financial Reporting Measures include, but are not limited to, the following accounting-based measures, and measures derived from such accounting-based measures:

Revenues;
Net income;
Operating income;
Profitability of one or more reportable segments;
EBITDA;
Funds from operations and adjusted funds from operations;
Liquidity measures, such as working capital and operating cash flow;
Return measures (e.g., ROIC, return on assets);
Financial ratios;
Earnings measures, such as earnings per share;
Share price; and
Total shareholder return.

Incentive-Based Compensation

Incentive-Based Compensation” means any compensation that is granted, earned, or vested based wholly or in part on the attainment of a Financial Reporting Measure. Incentive-Based Compensation may include, but is not limited to:

a.

Non-equity incentive plan awards that are earned based wholly or in part on satisfying a financial reporting measure performance goal;

b.

Bonuses paid from a “bonus pool,” the size of which is determined based wholly or in part on satisfying a financial reporting measure performance goal;

c.Other cash awards based on satisfaction of a financial reporting measure performance goal; d.Restricted stock, restricted stock units, performance share units, stock options, and stock appreciation rights that are granted or become vested based wholly or in part on satisfying a financial reporting measure performance goal; and

e.

Proceeds received upon the sale of shares acquired through an incentive plan that were granted or vested based wholly or in part on satisfying a financial reporting measure performance goal (including shares acquired with the proceeds of other forms of Incentive-Based Compensation pursuant to the terms of the applicable plan).

None of the following constitute Incentive-Based Compensation:

a.

Salaries;

b.

Bonuses paid solely at the discretion of the Board and not paid from a “bonus pool” that is determined by satisfying a financial reporting measure performance goal;

c.

Bonuses paid solely upon satisfying one or more subjective standards or completion of a specified employment period;

d.

Non-equity incentive plan awards earned solely upon satisfying one or more strategic measures or objectives (e.g., consummating a merger or divestiture), or operational measures (e.g., completion of a project, or increase in market share); and

e.

Equity awards for which (A) the grant is not contingent upon achieving any financial reporting measure performance goal and (B) vesting is contingent solely upon completion of a specified employment period and/or attaining one or more nonfinancial reporting measures.

Inception Date

Inception Date” means October 2, 2023, the effective date of Rule 313A.14 of the

NYSE Listed Company Rules.

Independent

Independent” means, with respect to a member of the Supervisory Board, that the Supervisory Board affirmatively determines that the member has no material relationship with the Company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the Company). In making such determination, the Supervisory Board shall consider all factors specifically relevant to

FOR INTERNAL USE ONLY

Page : 4 of 8


Graphic

Global Incentive-Based Compensation Recovery Policy

determining whether a member of the Supervisory Board has a relationship to the Company which is material to that member’s ability to be independent from management in connection with such member’s duties under this Policy, including, but not limited to:

a.

the source of compensation of such member, including any salary, consulting, advisory or other compensatory fee paid by the Company to such member; and

b.

whether such member is affiliated with the Company, a subsidiary of the Company or an affiliate of a subsidiary of the Company.

Without limiting the generality of the foregoing, a member of the Supervisory Board serving as such in accordance with the requirements of the German Co-Determination Act (Mitbestimmungsgesetz), shall be conclusively deemed not to be Independent for purposes of this Policy.

Received

Received” means the time at which an Executive Officer shall be deemed to have received Incentive-Based Compensation, which shall be the fiscal period of the Company during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive - Based Compensation occurs after the end of that period.

3

REQUIREMENTS / PROCESS

In the event the Company is required to prepare an Accounting Restatement due to material noncompliance by the Company with any financial reporting requirement under the U.S. federal securities laws, the Company will recover, reasonably promptly and to the fullest extent required by this Policy and applicable law, all excess Incentive-Based Compensation erroneously awarded by the Company and/or its subsidiaries, as the case may be. Such recovery shall be sought with respect to the periods for which, and from the Executive Officers from whom, such recovery is required by this Policy and applicable law.

This Policy shall apply to require recovery of excess Incentive-Based Compensation Received by an Executive Officer:

a.

after beginning service as an Executive Officer of the Company;

b.

who served as an Executive Officer at any time during the applicable performance period for that Incentive-Based Compensation;

c.

while a class of securities of the Company is listed on the NYSE, or on another U.S. national securities exchange; and

d.

during the three completed fiscal years immediately preceding the date that the Company is required to prepare an Accounting Restatement, plus any transition period resulting from a change in the Company’s fiscal year within or immediately following such three completed fiscal years.

3.1

Executives Covered by this Policy

This Policy applies to the current and former members of the Supervisory Board, the KGaA Supervisory Board, and the Management Board, and to the Company's other current and former Executive Officers (other than Management Board members) determined to be such by the Management Board in accordance with and consistent with the definition of such term set forth herein, Rule 10D-1 of the Commission and Rule 313A.14 of the NYSE Listed Company Rules.

3.2

Amount of Excess Incentive-Based Compensation Subject to Recovery

The amount of excess Incentive-Based Compensation recoverable from an Executive Officer of the Company in the event of an Accounting Restatement will be the amount of Incentive-Based Compensation Received by such Executive Officer, based on the relevant Financial Reporting Measure or Measures presented prior to the Accounting Restatement, that exceeds the amount

FOR INTERNAL USE ONLY

Page : 5 of 8


Graphic

Global Incentive-Based Compensation Recovery Policy

of Incentive-Based Compensation that such Executive Officer otherwise would have Received had such amount been determined based on the restated amounts.

Any such recoverable amount shall be computed without regard to taxes paid or payable on the excess amount. However, if and to the extent that the application of this Policy would provide for recovery of Incentive-Based Compensation that the Company has recovered or may recover from an Executive Officer pursuant to Section 304 of the Sarbanes -Oxley Act of 2002, the amount such Executive Officer has actually reimbursed the Company for such recovery shall be credited to the recovery required under this Policy.

If the applicable Board cannot determine the amount of excess Incentive-Based Compensation received by any Executive Office by means of a mathematical calculation directly from the information in the Accounting Restatement, then it will make its determination based on a reasonable estimate of the effect of the Accounting Restatement on the applicable measure.

3.3

Administration

Except as set forth in this Policy under the heading “Impracticability,” this Policy shall be administered by the Supervisory Board with respect to members of the Supervisory Board (if applicable) and members of the Management Board, and by the Management Board with respect to other Executive Officers covered by the Policy. Subject to the foregoing limitation with respect to Impracticability, the Supervisory Board may delegate its responsibility for the administration of this Policy to the Human Resources Committee of the Supervisory Board. To the extent responsibility for such administration may be delegated to it by the Supervisory Board, references herein to the Supervisory Board shall be deemed references to its Human Resources Committee. Any determinations made by the applicable Board in the administration of this Policy shall be final and binding on all affected individuals.

In administering this Policy, the Supervisory Board and the Management Board are authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. It is intended that this Policy be interpreted and applied consistently to members of the respective Boards and other Executive Officers and in a manner that is consistent with the requirements of Section 10D of the Exchange Act, Rule 10D-1 of the Commission thereunder and Rule 313A.14 of the NYSE Listed Company Rules, as each may in effect from time to time.

3.4

Method of Recovery

The applicable Board will determine, in its sole discretion, the method for recovering Incentive-Based Compensation hereunder. Such methods may vary by type of compensation or compensation system, and the applicable Board’s discretion shall include the discretion to utilize different means of recovery in different circumstances. The recovery methods chosen by a Board may include, without limitation:

a.

requiring reimbursement of cash Incentive-Based Compensation previously paid;

b.

seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;

c.

offsetting the recovered amount from any compensation otherwise owed by the Company or a subsidiary of the Company, as the case may be, to the relevant Executive Officer;

d.

cancelling outstanding vested or unvested equity awards; and/or

e.

taking any other remedial and recovery action permitted by applicable law, as determined by the applicable Board.

FOR INTERNAL USE ONLY

Page : 6 of 8


Graphic

Global Incentive-Based Compensation Recovery Policy

3.5

Impracticability

The Supervisory Board or the Management Board, as the case may be, shall recover any excess Incentive-Based Compensation in accordance with this Policy unless such recovery would be “impracticable,” within the meaning of paragraph (b)(1)(iv)(A), (b)(1)(iv)(B) or (b)(1)(iv)(C) of Rule 10D-1 of the Commission and Rule 313A.14 of the NYSE Listed Company Rules. Anything in this Policy to the contrary notwithstanding,  any determination to forego recovery of excess Incentive-Based Compensation on the ground of impracticability, including any required determination with respect to satisfaction of any of the applicable conditions set forth in paragraph (b)(1)(iv)(A), (b)(1)(iv)(B) or (b)(1)(iv)(C) of Rule 10D-1 (including, in each case and for the avoidance of doubt, any determination with respect to the impracticability of recovery of excess Incentive-Based Compensation paid to Executive Officers other than Management Board members), shall be made solely by a majority of the Independent directors serving on the Supervisory Board.

3.6

Indemnification; Insurance

The Company shall not indemnify any Board member or any other Executive Officer against the loss of any erroneously awarded Incentive-Based Compensation recovered by the Company. The Company shall neither provide for reimbursement of any Executive Officer for any such recovery by, or from the proceeds of, any directors and officers liability insurance policy maintained by the Company, nor pay or reimburse any Executive Officer for the premium costs of any insurance policy obtained directly by the Executive Officer insuring against such recovery.

3.7

Effective Date

This Policy shall be effective as of the date it is adopted by the Supervisory Board or the Management Board, as the case may be (in each case, the “Effective Date”) and shall apply to Incentive-Based Compensation that is Received by an Executive Officer on or after the Inception Date.

3.8

Amendment; Termination

This Policy may be amended from time to time by action of the Supervisory Board and the Management Board, and shall be amended as necessary to comply with Section 10D of the Exchange Act, Rule 10D-1 of the Commission thereunder, and the Listed Company Rules of the NYSE or such other U.S. national stock exchange on which the Company’s shares, or American Depositary Shares representing such shares, may be listed. Subject to such statutory provisions and rules, this Policy may be terminated by action of the Supervisory Board and the Management Board at any time.

3.9

Other Recovery Rights

It is intended that this Policy will be applied to the fullest extent required by applicable law. The applicable Board may require that any employment agreement, equity award agreement, performance share award or similar agreement entered into on or after the Effective Date, or any plan providing for Incentive-based Compensation adopted after the Effective Date shall, as a condition to the grant of any benefit thereunder, require the Executive Officer receiving same to agree to abide by the terms of this Policy. Save as provided above under the heading, “Amount of Excess Incentive-Based Compensation Subject to Recovery,” any right of recovery under this Policy is in addition to, and not in lieu of, any other remedies or rights of recovery that may be available to the Company pursuant to the terms of any applicable law or

FOR INTERNAL USE ONLY

Page : 7 of 8


Graphic

Global Incentive-Based Compensation Recovery Policy

regulation, or any similar policy in any employment agreement, equity award agreement, performance share award, or similar agreement and any other legal remedies available to the Company.

3.10

Successors

This Policy shall be binding and enforceable against all Executive Officers and their respective beneficiaries, heirs, executors, administrators or other legal representatives.

3.11

Effect of Conversion of Legal Form

Upon the registration in the Commercial Register (Handelsregister) of the local court (Amtsgericht) of Hof (Saale), Germany of the proposed conversion of the legal form of the Company from a partnership limited by shares (Kommanditgesellschaft auf Aktien) to a stock corporation (Aktiengesellschaft) under German law (the “Conversion”), this Policy shall continue in effect with respect to the present and former Executive Officers of the Company. From and after the effective date of the Conversion, pending adoption of a policy for recovery of excess Incentive-Based Compensation received by Executive Officers of the stock corporation, (i) “Company” shall mean the Company in the legal form of a stock corporation, (ii) “Supervisory Board” shall the Supervisory Board of the Company, and (iii) “Management Board” shall mean the Management Board of the Company, provided, that this Policy shall continue to require recovery of excess Incentive-based Compensation awarded to Executive Officers prior to the Conversion to the same extent as if the Conversion had not occurred.

4

RELATED INTERNAL CONTROLS

Subject

Title

None

5

RELATED DOCUMENTS

Document

Title

None

6

ANNEXES

Document

Title

None

FOR INTERNAL USE ONLY

Page : 8 of 8



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘20-F’ Filing    Date    Other Filings
Filed on:2/20/246-K
For Period end:12/31/23
10/2/23
 List all Filings 


17 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/09/23  Fresenius Medical Care AG &… KGaA 6-K         3/31/23   73:18M                                    Toppan Merrill/FA
 2/22/23  Fresenius Medical Care AG &… KGaA 20-F       12/31/22  181:42M                                    Toppan Merrill/FA
10/31/22  Fresenius Medical Care AG &… KGaA 6-K         9/30/22   72:13M                                    Toppan Merrill/FA
 8/02/22  Fresenius Medical Care AG &… KGaA 6-K         6/30/22   71:13M                                    Toppan Merrill/FA
 2/22/22  Fresenius Medical Care AG &… KGaA 20-F       12/31/21  184:44M                                    Toppan Merrill/FA
11/02/21  Fresenius Medical Care AG &… KGaA 6-K         9/30/21   70:21M                                    Toppan Merrill/FA
 7/30/21  Fresenius Medical Care AG &… KGaA 6-K         6/30/21   68:18M                                    Toppan Merrill/FA
 2/23/21  Fresenius Medical Care AG &… KGaA 20-F       12/31/20  184:42M                                    Toppan Merrill-FA
10/29/20  Fresenius Medical Care AG &… KGaA 6-K         9/30/20   63:12M                                    Toppan Merrill-FA
 7/30/20  Fresenius Medical Care AG &… KGaA 6-K         6/30/20   65:14M                                    Toppan Merrill-FA
 2/20/20  Fresenius Medical Care AG &… KGaA 20-F       12/31/19  181:43M                                    Toppan Merrill-FA
10/31/19  Fresenius Medical Care AG &… KGaA 6-K         9/30/19   86:13M                                    Toppan Merrill-FA
 7/30/19  Fresenius Medical Care AG &… KGaA 6-K         6/30/19  111:14M                                    Toppan Merrill-FA
 5/02/19  Fresenius Medical Care AG &… KGaA 6-K         3/31/19  111:13M                                    Toppan Merrill-FA
10/30/18  Fresenius Medical Care AG &… KGaA 6-K         9/30/18  109:15M                                    Toppan Merrill-FA
 2/22/17  Fresenius Medical Care AG &… KGaA 20-F       12/31/16  113:35M                                    Toppan Merrill-FA
11/04/14  Fresenius Medical Care AG &… KGaA 6-K        11/04/14   71:18M                                    Toppan Merrill-FA
Top
Filing Submission 0001104659-24-025293   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 2:41:03.2am ET